🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Sintilimab Plus Gossypol Acetate in Advanced Colorectal Cancer
NCT07656766Advanced Colorectal Cancer
Peking University People's Hospital
Phase 2
32
Beijing
2026-07-15
Recruiting
PEI-GT Trial for Initial Treatment of Primary Open-Angle Glaucoma With Cataract
NCT07700498Primary Open Angle Glaucoma and Cataracts
Nanfang Hospital, Southern Medical University
Not applicable
106
Ningxia, Guangzhou, Luzhou, Zhengzhou, Zhuhai
2026-07-15
Not yet open
Study on the Incremental Predictive Value of Early Resting-State EEG Phenotypes for Functional Prognosis and Risk Stratification in Acute Ischemic Stroke
NCT07741669Stroke
Xuanwu Hospital, Beijing
Observational
5
Beijing
2026-07-15
Not yet open
Evaluating Antiplatelet and Physical Therapy for Slowing Progression in Mild Moyamoya Disease.
NCT07762547Moyamoya Disease, Moyamoya Syndrome, Aspirin, Remote Ischemic Conditioning
Beijing Tiantan Hospital
Not applicable
724
Beijing
2026-07-15
Not yet open
Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)
NCT07662863Bladder Cancer, Metastatic Urothelial Carcinoma, Urothelial Carcinoma, Peripheral Neuropathy
Fudan University
Phase 2
75
Shanghai
2026-07-15
Not yet open
Development of a Digital Acceptance and Commitment Therapy Intervention for Suicide Prevention in Adults Through Co-design
NCT07733596Suicide, Co-design, Suicide Prevention
The Hong Kong Polytechnic University
Not applicable
80
Hong Kong
2026-07-15
Recruiting
Acupoint Application for Chemotherapy-Induced Nausea and Vomiting in Lung Cancer
NCT07768124Lung Cancer (Diagnosis)Chemotherapy-Induced Nausea and Vomiting
Xiu Huang
Not applicable
60
Chongqing
2026-07-15
Not yet open
Development and Validation of a Colorectal Cancer Diagnostic Model
NCT07692555Colorectal Cancer, Advanced Neoplasia, Prediction Models, Risk Stratification
Peking University Cancer Hospital & Institute
Observational
20,000
Beijing, Fuzhou, Xiamen, Yinchuan
2026-07-15
Not yet open
Efficacy of Lymphatic-Venous Anastomosis Plus Donepezil Versus Donepezil Alone for Alzheimer's Disease
NCT07680660Alzheimer s Disease
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
216
Shanghai
2026-07-15
Recruiting
A Study of SKB571 Combination Therapy in Participants With Non-Small Cell Lung Cancer (NSCLC)
NCT07622186Non-Small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
150
Beijing, Chongqing, Fuzhou, Xiamen, Dongguan, Guangzhou, Guilin, Nanning
2026-07-15
Not yet open
Selumetinib for NF2-Related Schwannomatosis
NCT07707947Neurofibromatosis Type 2, NF2, NF2-related Schwannomatosis, Meningioma
Beijing Tiantan Hospital
Phase 2
20
Beijing
2026-07-15
Recruiting
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Not yet open
A National Multicenter Study of Etrasimod for the Treatment of Patients With Active UC
NCT07705126Ulcerative Colitis (UC)
Tang-Du Hospital
Observational
500
Xi’an
2026-07-15
Recruiting
PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC
NCT07697859Esophageal Squamous Cell Carcinoma (ESCC)
Fudan University
Observational
354
Shanghai
2026-07-15
Not yet open
Comparison of Postoperative Functional Outcomes Between Subvastus and Medial Parapatellar Approach in Total Knee Arthroplasty
NCT07742696Osteoarthritis (OA) of the Knee
Peking University Third Hospital
Not applicable
84
Beijing
2026-07-15
Recruiting
A Study of SYH2070 Injection in Participants With Mixed Hyperlipidemia
NCT07695597Mixed Hyperlipidemia
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase 2
240
Hangzhou
2026-07-15
Not yet open
SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
NCT07683221Pancreatic Cancer
Shandong Cancer Hospital and Institute
Phase 2
47
Jinan
2026-07-15
Recruiting
Toludesvenlafaxine for Non-specific Low Back Pain
NCT07709416Non-specific Low Back Pain
Beijing Tiantan Hospital
Not applicable
132
Beijing
2026-07-15
Recruiting
MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
NCT07694752Urethral Internal Sphincter Morphology, Benign Prostatic Hyperplasia, Prostate Cancer
Jiangsu Taizhou People's Hospital
Observational
80
Taizhou
2026-07-15
Not yet open
Becotatug Vedotin Combined With Pucotenlimab ± Radiotherapy as First-Line Treatment for Driver-Gene-Negative, EGFR-Expression-Positive Advanced Non-Small Cell Lung Cancer
NCT07627321NSCLC (Advanced Non-small Cell Lung Cancer)
Anhui Provincial Cancer Hospital
Phase 2
39
Hefei
2026-07-15
Recruiting
Modified Mini-PCNL Versus Standard PCNL for Complex Kidney Stones
NCT07697677Kidney Stones, Complex Renal Calculi
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
1,380
Guangzhou
2026-07-15
Recruiting
Evaluation of Bioequivalence and Food Effect of a New Strength Formulation of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy Participants.
NCT07756996Healthy Participants
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1
62
Suzhou
2026-07-15
Recruiting
Early Identification and Diagnosis of BAD-related Stroke
NCT07693816Branch Atheromatous Disease, Acute Ischemic Stroke, Cerebral Infarction
Peking Union Medical College Hospital
Observational
1,602
Beijing
2026-07-15
Not yet open
Endoscopic Ultrasound-Guided Ethanol Ablation for Aldosterone-Producing Adenoma
NCT07700472Primary Aldosteronism, Aldosterone-Producing Adenoma
Chongqing Medical University
Not applicable
30
Chongqing
2026-07-15
Recruiting
Orelabrutinib Combined With Obinutuzumab and Short-Course Venetoclax in Patients With Treatment-Naïve Mantle Cell Lymphoma (MCL)
NCT07719556Mantle Cell Lymphoma (MCL)
The First Affiliated Hospital with Nanjing Medical University
Phase 2
39
Changzhou, Nanjing
2026-07-15
Not yet open
A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer
NCT07621159Colorectal Cancer Metastatic
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1/2
120
Beijing
2026-07-15
Recruiting
Age-Stratified Conditioning Regimen Efficacy for MDS Haplo-HSCT
NCT07677306Myelodysplastic Syndromes
Peking University People's Hospital
Phase 2
120
Beijing
2026-07-15
Active, closed
Research and Application Evaluation of Accurate Pressure Ulcer Area Measurement Technology Based on AI Grid Intelligent Recognition: A Self-controlled Study
NCT07743385Pressure Ulcers, Pressure Injuries
Affiliated Hospital of Nantong University
Not applicable
100
Bengbu, Nantong, Hangzhou
2026-07-14
Recruiting
Catheter-Oriented Unloading and Recovery With a Left Ventricular Assist Gear: Efficacy in Post Cardiotomy Cardiogenic Shock
NCT07560085Cardiogenic Shock
ForQaly Medical (Shanghai) Co., Ltd
Not applicable
60
Fuzhou, Wuhan
2026-07-14
Recruiting
A Pharmacokinetic Study of D-2570 in Participants With Hepatic Impairment and Normal Hepatic Function
NCT07715149Healthy Adult Participants, Hepatic Impairment (HI)
InventisBio Co., Ltd
Phase 1
24
Bengbu
2026-07-14
Recruiting
A Study on the Efficacy and Safety of TEER Combined With Electrical Cardioversion in Patients With Severe Mitral Regurgitation and Atrial Fibrillation
NCT07741383Atrial Fibrillation Mitral Valve Insufficiency
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
570
Hangzhou
2026-07-14
Recruiting
Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors
NCT07691619Thymic Epithelial Tumor
Tianjin Medical University Cancer Institute and Hospital
Phase 2
49
Tianjin
2026-07-14
Recruiting
A Research Study to Investigate the Efficacy and Safety of HRS9531 Tablets in Participants With Type 2 Diabetes Mellitus
NCT07599410T2DM
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 2
240
Beijing, Jinan
2026-07-14
Not yet open
Early Response-guided Sequential Radiotherapy After Chemoimmunotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
NCT07721103Esophageal Squamous Cell Carcinoma (ESCC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
110
Tianjin
2026-07-14
Recruiting
A Multicenter, Open-label Study on the Efficacy and Safety of Tebiovio® (Adalimumab) in Treating Chinese Children With Severe Plaque Psoriasis
NCT07663331Adult Non-infectious Uveitis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 4
30
Tianjin
2026-07-14
Recruiting
A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
NCT07609823Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
75
Nanjing
2026-07-14
Recruiting
A Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies
NCT07609862Mantle Cell Lymphoma (MCL), Diffuse Large B-Cell Lymphoma (DLBCL), Follicular Lymphoma ( FL), Waldenström Macroglobulinemia (WM)
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 1/2
92
Tianjin
2026-07-14
Recruiting
Safety, Tolerability, and Preliminary Antitumor Activity of Cationic Peptide-IL22BP mRNA in Advanced Solid Tumors
NCT07583654mRNA Vaccine, Solid Tumor Cancer, Peptides, Cancer Metastatic
West China Hospital
Phase 1
18
Chengdu
2026-07-13
Recruiting
Guo&Amp;'s Distal Entry Tear Repair With WeFlow-EndoPatch System (Gallant Study)
NCT06945809Aortic Dissection, Distal Entry Tear
Hangzhou Endonom Medtech Co., Ltd.
Not applicable
216
Beijing
2026-07-13
Not yet open
The Effect of Ligament of Marshall Excision During Minimally Invasive Cardiac Surgery-Coronary Artery Bypass Grafting (MICS-CABG) on the Prevention of Postoperative New-Onset Atrial Fibrillation: A Multicenter, Prospective, Randomized, Triple-Blinded Study
NCT07755072Postoperative Atrial Fibrillation
Peking University Third Hospital
Not applicable
628
Beijing
2026-07-13
Not yet open
Development of a Risk Prediction Model for Post-Spinal Anesthesia Hypotension During Cesarean Delivery Using Heart Rate, Blood Pressure, Perfusion Index, ECG Waveforms, and SpO₂ Waveforms
NCT07689825Cesarean Section
Peking University Shenzhen Hospital
Observational
145
Shenzhen
2026-07-13
Not yet open
Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic Cancer
NCT07745790Pancreatic Ductal Adenocarcinoma, Liver Neoplasms, Lung Neoplasms
Ruijin Hospital
Phase 2
20
Shanghai
2026-07-13
Not yet open
Comparison of Two Rotational Alignment Methods for Astigmatism Correction in SMILE Surgery
NCT07696468Myopia, Refractive Ametropia
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
52
Guangzhou
2026-07-13
Recruiting
A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC
NCT07424287NMIBC
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 3
236
Beijing, Shanghai
2026-07-13
Recruiting
Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)
NCT07567625Acute Myocardial Infarction (AMI), ST-Segment Elevation Myocardial Infarction(STEMI), Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)
Harbin Medical University
Not applicable
2,000
Harbin, Beijing, Cangzhou, Chengde, Chengdu, Dalian, Daqing, Hunan
2026-07-13
Not yet open
Finerenone and Empagliflozin Combination in Obesity With Hypertension: A 12-Week Prospective, Parallel-design, Double-blind, Randomized, Placebo-controlled Trial
NCT07678151Hypertension (HTN)
Heart Health Research Center
Not applicable
260
Beijing, Luoyang
2026-07-13
Not yet open
JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC
NCT07714304NSCLC Harboring EGFR Mutations
Huan Zhou
Not applicable
20
Hefei, Shanghai
2026-07-13
Not yet open
Cardiovascular Risk in T2DM With MAFLD: A Cohort Study
NCT07706010Type 2 Diabetes (T2DM), Metabolic Dysfunction-Associated Steatotic Liver Disease
The Affiliated Hospital of Hangzhou Normal University
Observational
7,000
Hanzhou
2026-07-12
Not yet open
A Phase II Study of H021 Enteric-coated Tablets for Moderately to Severely Active Crohn's Disease
NCT07677514Crohn's Disease
Jiangsu Carephar Pharmaceutical Co., Ltd.
Phase 2
156
Beijing, Bengbu, Changsha, Chongqing, Fujian, Guangzhou, Hefei, Huizhou
2026-07-12
Recruiting
Effects of Fospropofol Disodium TIVA and IVIH on Surgical Field Quality in Adult ESS
NCT07788157Fospropofol Disodium
Tongji Hospital
Not applicable
144
Wuhan
2026-07-12
Recruiting
Polypills Approach for Multiple Cardiovascular Risk Factors
NCT07679828Hypertension, Dyslipidemia, Diabetes
China Medical University, China
Not applicable
8,252
Zhengzhou, Chifeng, Tongliao, Kunshan, Suzhou, Taizhou, Jinzhou, Panjin
2026-07-11
Not yet open
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
NCT07751588Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Observational
25
Tianjin
2026-07-11
Not yet open
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
NCT07658339COPD (Chronic Obstructive Pulmonary Disease)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
387
Beijing
2026-07-11
Recruiting
Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
NCT07692841Healthy Hematopoietic Stem Cell Donor, Healthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University
Phase 3
560
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
Study of GST-HG131&141 Tablets Compared With Placebo in Patients With Chronic Hepatitis B
NCT07709520Chronic Hepatitis B
Fujian Akeylink Biotechnology Co., Ltd.
Phase 2
80
Beijing
2026-07-10
Recruiting
Preconception vs First-Trimester Screening and Treatment for Iron Deficiency Anemia
NCT07811765Iron Deficiency Anemia
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
960
Zhaotong
2026-07-10
Recruiting
Safety and Efficacy of Eculizumab in High-risk TA-TMA
NCT07707687Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
First Affiliated Hospital of Zhejiang University
Phase 2
24
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Not yet open
Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Mature B-cell Lymphoma
NCT07459608Indolent Lymphoma, WM, MZL, CLL / SLL
Henan Cancer Hospital
Phase 2
75
Zhengzhou
2026-07-10
Recruiting
Adjuvant Moderately Hypofractionated Intensity-modulated Radiotherapy for Cervical Cancer
NCT07684508Hypofractionated Radiotherapy, Intensity-modulated Radiotherapy, Cervical Cancers
Manni Huang
Not applicable
154
Beijing, Langfang
2026-07-10
Recruiting
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
NCT07669779Advanced Non Small Cell Lung Cancer (NSCLC)
Akeso
Phase 2
348
Guangzhou
2026-07-10
Not yet open
Ultrasound Screening for Early Detection of Breast Cancer in Elderly Women: A Mixed Cluster-Individual RCT
NCT07698366Breast Neoplasms, Early Detection of Cancer
The First Affiliated Hospital with Nanjing Medical University
Not applicable
82,440
Kunshan
2026-07-10
Not yet open
PulseMagic™ TrueForce™ PAF NMPA Study
NCT07720557Atrial Fibrillation (AF), Paroxysmal AF, Drug Refractory Paroxysmal Atrial Fibrillation, Atrial Arrhythmia
Shanghai MicroPort EP MedTech Co., Ltd.
Not applicable
150
Beijing
2026-07-10
Not yet open
A Phase II Clinical Trial Evaluating the Efficacy and Safety of SYS6026 Injection in Participants With HPV16 or 18-related High-grade Cervical Squamous Intraepithelial Lesions
NCT07702656High-grade Cervical Intraepithelial Lesions
CSPC Megalith Biopharmaceutical Co.,Ltd.
Phase 2
175
Shijiazhuang
2026-07-10
Not yet open
Combined Magnetic Stimulation and Ultrasound for Detrusor Overactivity in SCI
NCT07704268Spinal Cord Injuries
Shengjing Hospital
Not applicable
44
Shenyang
2026-07-10
Not yet open
Neoadjuvant Short-Course Radiotherapy Plus Tislelizumab and Chemotherapy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT07678580Esophageal Squamous Cell Carcinoma (ESCC)
Tang-Du Hospital
Phase 2
50
Xi'an
2026-07-10
Recruiting
A Study to Investigate ANS02 in Participants With EGFR Mutation-Positive Non-Small Cell Lung Cancer
NCT07538804Non-Small Cell Lung Cancer
Avistone Biotechnology Co., Ltd.
Phase 1/2
294
Guangzhou, Harbin, Zhengzhou, Chengdu
2026-07-10
Active, closed
ThromBus Aspiration for Acute Mesenteric Artery Occlusion With Emergent Laparoscopic Surgery
NCT07741318Acute Mesenteric Ischemia
Beijing Tsinghua Chang Gung Hospital
Not applicable
76
Beijing
2026-07-10
Recruiting
Multimodal Ocular Diagnosis-Guided Precision Acupuncture and Lifestyle Intervention for PCOS
NCT07809503Polycystic Ovary Syndrome
Peking University Third Hospital
Not applicable
210
Beijing
2026-07-10
Recruiting
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Profile of YKYY033 Injection
NCT07786779Venous Thromboembolism (VTE)
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.
Phase 1
40
Beijing
2026-07-10
Recruiting
Comparison of Three Airway Intubation Devices for First-Attempt Success in General Anesthesia Patients
NCT07699653Airway Management, General Anesthesia, Tracheal Intubation
Guangzhou University of Chinese Medicine
Not applicable
549
Guangzhou
2026-07-10
Recruiting
A Study of MI078 for Postpartum Depression
NCT07721961Postpartum Depression (PPD)
Nanjing Minova Pharmaceutical Co., Ltd.
Phase 3
200
Hefei, Chongqing, Xiamen, Lanzhou, Guangzhou, Zhaoqing, Liuzhou, Guiyang
2026-07-10
Recruiting
Efficacy and Underlying Mechanisms of Group Natural Psychotherapy for Anxiety Symptoms
NCT07731568Anxiety Symptoms
Beijing HuiLongGuan Hospital
Not applicable
55
Beijing
2026-07-10
Not yet open
Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD
NCT07634367COPD (Chronic Obstructive Pulmonary Disease)
Haisco Pharmaceutical Group Co., Ltd.
Phase 3
300
Nanchang
2026-07-10
By invitation
A Simulated Case Study of a Peritoneal Dialysis-Specialized Large Language Model Assisting Doctors in Improving Decision-Making in Peritoneal Dialysis Management
NCT07724327Peritoneal Dialysis (PD), Large Language Models
First Affiliated Hospital, Sun Yat-Sen University
Not applicable
100
Guangzhou
2026-07-10
Recruiting
DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard Chemotherapy
NCT07544654Extrapulmonary Neuroendocrine Cancer (epNEC)
Boehringer Ingelheim
Phase 3
390
Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou
2026-07-10
Not yet open
Eltrombopag Plus Telitacicept vs. Eltrombopag Alone for Steroid-refractory/Relapsed ITP
NCT07687134Immune Thrombocytopenia
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
40
Tianjin
2026-07-10
Not yet open
Rucaparib Monoclonal Antibody for Lorlatinib-Induced Hypercholesterolemia / Mixed
NCT07674368ALK Fusion-positive Non-small Cell Lung Cancer
Hunan Cancer Hospital
Phase 4
29
Changsha
2026-07-10
Recruiting
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers
NCT07688460Alzheimer Disease
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Phase 4
100
Yiwu
2026-07-10
Not yet open
Acupuncture Versus Sham Acupuncture for Tinnitus
NCT07700069Tinnitus
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
226
Shanghai
2026-07-10
Recruiting
A Clinical Study Evaluating the Pharmacokinetic Characteristics and Safety of AHB-137 Injection in Participants With Mild to Moderate Liver Dysfunction and Those With Normal Liver Function.
NCT07600788Chronic Hepatitis B
Ausper Biopharma Co., Ltd.
Phase 1
32
Chongqing, Zhengzhou, Shanghai, Chengdu, Hangzhou
2026-07-09
Recruiting
A Study of BL-M14D1 in Combination With Atezolizumab in Patients With Extensive-stage Small Cell Lung Cancer
NCT07654400Extensive-stage Small-cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
36
Shanghai
2026-07-09
Recruiting
A Clinical Trial Evaluating the Tolerability, Safety, and Preliminary Efficacy of NRG-103 Injection in Patients With Recurrent or Progressive High-grade Glioma
NCT07710690HGG, High Grade Glioma (III or IV), High Grade Glioma
Neuregen Therapeutics Co., Ltd.
Phase 1
24
Shanghai, Wuhan, Xi'an
2026-07-09
Not yet open
A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors
NCT07695142Advanced Solid Tumor (Phase 1)
Haisco Pharmaceutical Group Co., Ltd.
Phase 1
275
Shanghai
2026-07-09
Recruiting
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
NCT07567872COPD
Guangdong Hengrui Pharmaceutical Co., Ltd
Phase 1
48
Chengdu
2026-07-09
Not yet open
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation
NCT07703657Allogeneic Hematopoietic Stem Cell Transplantation, Epstein-Barr Virus Reactivation, Clinically Significant EBV DNAemia
Yang Donglin
Not applicable
168
Tianjin
2026-07-09
Not yet open
Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients
NCT07703644Hematologic Neoplasms, Gram-Negative Bacterial Infections, Pseudomonas Aeruginosa Infection, Klebsiella Pneumoniae Infections
Sizhou Feng
Observational
60
Tianjin
2026-07-09
Recruiting
A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.
NCT07496177T2DM, CKD
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
Phase 2
75
Weifang
2026-07-09
Recruiting
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin
NCT07664553Type 2 Diabetes Mellitus
AstraZeneca
Phase 3
600
Changsha, Hefei, Huai'an, Langfang, Liangyugang, Luoyang, Nanjing, Nanyang
2026-07-08
Active, closed
A Prospective Study of Cold Exposure in Patients With MASH
NCT07821749Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Renmin Hospital of Wuhan University
Not applicable
11
Wuhan
2026-07-08
Recruiting
A Phase II/III Study of F520 Combined With Paclitaxel Plus Carboplatin in the Treatment of Cancer of Unknown Primary (CUP)
NCT07761429Cancer of Unknown Primary Site
Shandong New Time Pharmaceutical Co., LTD
Phase 2/3
402
Shanghai
2026-07-08
Not yet open
The Longitudinal Cohort of Cerebral Small Vessel Disease in Ruijin Hospital
NCT07726654Cerebral Small Vessel Disease
Ruijin Hospital
Observational
400
Shanghai
2026-07-08
Recruiting
Timing of ctDNA Testing in Advanced Breast Cancer
NCT07681323Advanced Breast Cancer
Geneplus-Beijing Co. Ltd.
Observational
400
Beijing
2026-07-08
Recruiting
Intensive vs. Standard Blood Pressure Control in Primary Aldosteronism
NCT07673445Primary Aldosteronism
Chongqing Medical University
Not applicable
3,830
Chongqing
2026-07-07
Recruiting
A Study of BL-M07D1 Versus Physician's Choice of Chemotherapy in Patients With HER2-expressing Locally Advanced or Metastatic Biliary Tract Cancer After Platinum-containing Chemotherapy Failure
NCT07606599Biliary Tract Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 3
398
Hefei, Beijing
2026-07-07
Not yet open
Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)
NCT07535489Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd
Phase 2
144
Beijing
2026-07-07
Recruiting
A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer
NCT07623356Non-Small Cell Lung Cancer
Akeso
Phase 1/2
265
Shanghai
2026-07-07
Recruiting
CD38 Targeted -PET/ CT for Multiple Myeloma
NCT07782944Multiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma
Guilin Medical University, China
Not applicable
100
Guilin
2026-07-07
Recruiting
MRD-Guided BCMA/CD3 Bispecific Antibody Treatment After Stem Cell Transplant for Newly Diagnosed Multiple Myeloma
NCT07409454Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2026-07-07
Not yet open
An Umbrella-designed Prospective Multicenter Randomized Open-label Superiority Trial Evaluating Multi-biomarker-guided Precision Therapy for First-line Treatment of Advanced Esophageal Squamous Cell Carcinoma
NCT07709533Valid MeSH Conditions
Sun Yat-sen University
Phase 2
347
Guangdong
2026-07-07
Not yet open
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of Intracerebral Injection of LY-N001 Injection for the Treatment of Moderate to Advanced Parkinson's Disease With GBA1 Mutations
NCT07685444Parkinson's Disease (PD)
Lingyi Biotech Co., Ltd.
Phase EARLY_PHASE1
18
Hefei
2026-07-07
Rows per page Showing 1201–1300 of 19052
Previous 11 12 13 14 15 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=13

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.